Xylocaine-Mpf 1% Inj, 5ml
Overview
What is this medicine?
How to Use This Medicine
For storage and disposal, consult with your doctor, nurse, or pharmacist to determine the best approach if you need to keep this medication at home.
If you miss a dose, contact your doctor immediately to receive guidance on the appropriate course of action.
Lifestyle & Tips
- Avoid eating or drinking until sensation returns if the mouth or throat is numbed to prevent choking.
- Avoid activities requiring fine motor skills or alertness until the effects of the anesthetic wear off, especially if large areas are numbed or if you feel drowsy.
- Protect the numbed area from injury (e.g., burns, cuts) as you won't feel pain.
Available Forms & Alternatives
Available Strengths:
- Xylocaine 4% Top Soln
- Xylocaine-Mpf 2% Inj, 10ml
- Xylocaine 2% Inj, 10ml
- Xylocaine-Mpf 1% Inj, 5ml
- Xylocaine 2% Inj, 20ml
- Xylocaine-Mpf 1% Inj, 30ml
- Xylocaine 2% Inj, 50ml
- Xylocaine-Mpf 0.5% Inj, 50ml
- Xylocaine-Mpf 1% Inj, 2ml
- Xylocaine-Mpf 2% Inj, 5ml
- Xylocaine 1% Inj, 20ml
- Xylocaine-Mpf 2% Inj, 2ml
- Xylocaine-Mpf 1% Inj, 10ml
- Xylocaine 1% Inj, 50ml
- Xylocaine 0.5% Inj, 50ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of methemoglobinemia, a rare but potentially deadly condition, such as:
+ Blue or gray discoloration of the lips, nails, or skin
+ Abnormal heartbeat
+ Seizures
+ Severe dizziness or fainting
+ Severe headache
+ Excessive sleepiness
+ Fatigue or weakness
+ Shortness of breath
Signs of acidosis (too much acid in the blood), such as:
+ Confusion
+ Rapid breathing
+ Rapid heartbeat
+ Abnormal heartbeat
+ Severe stomach pain, nausea, or vomiting
+ Excessive sleepiness
+ Shortness of breath
+ Fatigue or weakness
Other severe side effects, including:
+ Breathing difficulties, such as slow, shallow, or troubled breathing
+ Feeling lightheaded, sleepy, confused, or experiencing blurred vision
+ Slow heartbeat
+ Feeling nervous or excitable
+ Speech difficulties
+ Abnormal sensations, such as burning, numbness, or tingling
+ Restlessness
+ Anxiety
+ Changes in vision
+ Ringing in the ears
+ Dizziness or fainting
+ Severe headache
+ Twitching
+ Shakiness
+ Seizures
+ Feeling excessively hot or cold
+ Metallic taste
+ Chest pain
+ Mood changes
Additional Side Effects
This medication can cause other side effects, which may be mild or severe. If you experience any side effects that bother you or do not go away, contact your doctor or seek medical attention.
Specific Side Effects with Spinal Injection
If you receive this medication via spinal injection, you may be at risk for additional side effects, including:
Erectile dysfunction
Loss of motor function
Loss of bladder or bowel control
Urinary retention
Reporting Side Effects
If you experience any side effects, you can report them to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch. You can also contact your doctor for medical advice about side effects.
Seek Immediate Medical Attention If You Experience:
- Dizziness or lightheadedness
- Ringing in the ears (tinnitus)
- Numbness or tingling around the mouth
- Unusual taste in the mouth (metallic taste)
- Blurred vision or double vision
- Tremors or muscle twitching
- Feeling unusually sleepy or confused
- Slow or irregular heartbeat
- Difficulty breathing
Before Using This Medicine
To ensure safe treatment, inform your doctor of the following:
Any allergies you have to this medication, its components, or other substances, including foods and drugs. Describe the allergic reactions you have experienced.
If you are scheduled to receive this medication via spinal injection, notify your doctor if you have:
+ Heart block
+ Severe bleeding
+ Severe infection
+ An infection at the injection site
It is crucial to disclose all your health conditions and medications to your doctor and pharmacist, including:
Prescription and over-the-counter (OTC) medications
Natural products
* Vitamins
This will help determine if it is safe to take this medication with your existing health conditions and other medications. Never start, stop, or adjust the dosage of any medication without consulting your doctor first.
Precautions & Cautions
It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.
Risk of Methemoglobinemia
A severe blood condition called methemoglobinemia has been associated with drugs like this one. Your risk may be increased if you have:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Heart problems
- Lung problems
- Are taking certain other medications
- Are an infant younger than 6 months of age
If you have a history of methemoglobinemia, notify your doctor.
Sulfite Allergy
If you are allergic to sulfites, consult with your doctor, as some products may contain sulfites.
Caution with Daily Activities
Avoid driving and engaging in activities that require alertness until the effects of this medication have worn off and you feel fully awake.
Post-Treatment Precautions
If you are discharged before the numbness has resolved, take necessary precautions to protect the treated area from injury until sensation has returned.
Special Considerations
- If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
- If the patient is a child, use this medication with caution, as the risk of certain side effects may be higher in children.
- If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks with your doctor.
Injection into the Spine
This medication may cause temporary loss of feeling and motor function in the lower half of your body. Do not attempt to get out of bed or perform other activities until normal sensation and motor function have returned.
Mouth and Dental Procedures
Do not eat while your mouth feels numb, as you may inadvertently bite your tongue.
Overdose Information
Overdose Symptoms:
- Severe dizziness or lightheadedness
- Seizures
- Unconsciousness
- Slow or irregular heartbeat (bradycardia)
- Low blood pressure (hypotension)
- Cardiac arrest
- Respiratory arrest
What to Do:
Seek immediate medical attention. Call 911 or your local emergency number. In the US, you can call Poison Control at 1-800-222-1222.
Drug Interactions
Major Interactions
- Antiarrhythmics (Class I, e.g., mexiletine, tocainide): Increased risk of cardiac depression and CNS toxicity.
- Beta-blockers (e.g., propranolol, metoprolol): May decrease lidocaine clearance, increasing plasma levels and toxicity risk.
- Cimetidine: May decrease lidocaine clearance, increasing plasma levels and toxicity risk.
Moderate Interactions
- CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin): May increase lidocaine levels.
- CYP3A4 inhibitors (e.g., macrolide antibiotics, azole antifungals, protease inhibitors): May increase lidocaine levels.
- Skeletal muscle relaxants (e.g., succinylcholine): May prolong neuromuscular blockade.
- Phenytoin: May increase lidocaine metabolism, but also increased risk of cardiac depression.
Minor Interactions
- Other local anesthetics: Additive systemic toxicity.
Monitoring
Baseline Monitoring
Rationale: To identify hypersensitivity reactions to lidocaine or other amide-type local anesthetics.
Timing: Prior to administration
Rationale: To establish baseline and identify pre-existing cardiovascular or respiratory compromise.
Timing: Prior to administration
Rationale: To assess risk factors for systemic toxicity (e.g., hepatic impairment, cardiac disease).
Timing: Prior to administration
Routine Monitoring
Frequency: During and immediately after administration, then as clinically indicated.
Target: Within patient's normal range.
Action Threshold: Significant deviations (e.g., bradycardia, hypotension, respiratory depression) require immediate intervention.
Frequency: Continuously during and for at least 30 minutes after administration.
Target: Absence of symptoms.
Action Threshold: Any signs of CNS toxicity (e.g., dizziness, tinnitus, perioral numbness, seizures) or cardiovascular toxicity (e.g., bradycardia, hypotension, arrhythmias) require immediate intervention.
Frequency: During and immediately after administration.
Target: Alert and oriented.
Action Threshold: Drowsiness, confusion, or loss of consciousness.
Symptom Monitoring
- Lightheadedness
- Dizziness
- Tinnitus
- Perioral numbness
- Metallic taste
- Blurred vision
- Tremors
- Muscle twitching
- Seizures
- Drowsiness
- Confusion
- Bradycardia
- Hypotension
- Cardiac arrest
- Respiratory depression
Special Patient Groups
Pregnancy
Category B. Studies in animals have shown no evidence of harm to the fetus. Adequate and well-controlled studies in pregnant women are lacking, but human experience with lidocaine for local anesthesia during pregnancy (e.g., epidural for labor) suggests no adverse effects on fetal development. Use only if clearly needed.
Trimester-Specific Risks:
Lactation
Lidocaine is excreted into breast milk in small amounts. The amount ingested by the infant is generally considered too small to cause adverse effects. Compatible with breastfeeding (L2).
Pediatric Use
Dose must be carefully calculated based on weight and age to avoid systemic toxicity. Use the lowest effective dose. Neonates and infants may have reduced protein binding and hepatic metabolism, increasing risk of toxicity.
Geriatric Use
Reduced doses may be required due to age-related decreases in hepatic blood flow, hepatic metabolism, and renal function. Increased susceptibility to systemic toxicity. Monitor closely for adverse effects.
Clinical Information
Clinical Pearls
- Xylocaine-MPF (Methylparaben Free) is specifically formulated without methylparaben, making it suitable for epidural and spinal anesthesia where preservatives can cause neurotoxicity.
- Always aspirate prior to injection to avoid inadvertent intravascular administration, which can lead to rapid systemic toxicity.
- The addition of epinephrine prolongs the duration of action and reduces systemic absorption, but should be avoided in areas with end-arterial circulation (e.g., fingers, toes, nose, ears, penis) due to risk of ischemia.
- Systemic toxicity typically manifests as CNS symptoms first (e.g., circumoral numbness, tinnitus, lightheadedness), followed by seizures, and then cardiovascular depression (bradycardia, hypotension, arrhythmias, cardiac arrest).
- Lipid emulsion therapy (Intralipid) is the antidote for severe local anesthetic systemic toxicity (LAST).
Alternative Therapies
- Bupivacaine (longer acting)
- Ropivacaine (less cardiotoxic than bupivacaine)
- Mepivacaine
- Prilocaine
- Chloroprocaine (ester-type, very short acting)